Search Results - Hitre, E.

Phase 3 multicenter, open-label, randomized study of infigratinib versus gemcitabine plus cisplatin in the first-line treatment of patients with advanced cholangiocarcinoma with FG... by Javle, Milind (Author) , Borbath, I. (Author) , Clarke, S. (Author) , Hitre, E. (Author) , Louvet, C. (Author) , Macarulla, T. (Author) , Oh, D. (Author) , Spratlin, J. (Author) , Valle, J. (Author) , Weiss, Karl Heinz (Author) , Berman, C. (Author) , Howland, M. (Author) , Ye, Y. (Author) , Cho, T. (Author) , Moran, S. (Author) , Abou-Alfa, G. (Author) ,

• Verlag, lizenzpflichtig
• Verlag, lizenzpflichtig